Therapeutic viruses help turbocharge the immune system against cancer

by Richard Harth,Arizona State UniversityThe illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how

Updated on: January 30,2024

Therapeutic viruses help turbocharge the immune system against cancer

by Richard Harth,Arizona State UniversityThe illustration shows a cancer cell (center) surrounded by immune T-cells augmented with an oncolytic (cancer-fighting) virus. A new study describes how

Updated on:January 30,2024

Cancer patients should be told more about their fertility options

by Medical Journal of AustraliaCredit: Drew Hays/UnsplashFertility preservation care for people with cancer is "often underimplemented" with barriers needing to be overcome, according to aut

Updated on: December 18,2023

Cancer patients should be told more about their fertility options

by Medical Journal of AustraliaCredit: Drew Hays/UnsplashFertility preservation care for people with cancer is "often underimplemented" with barriers needing to be overcome, according to aut

Updated on:December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

Researchers testing new brain cancer vaccine

by Rush University Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Rush University Medical Center is part of a new clinical trial testing whether an experimental vacci

Updated on: June 01,2024

Researchers testing new brain cancer vaccine

by Rush University Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Rush University Medical Center is part of a new clinical trial testing whether an experimental vacci

Updated on:June 01,2024

Trial results support 'new gold standard' for head and neck cancer radiotherapy

byInstitute of Cancer ResearchRadiotherapy IMRT. Credit: Jan Chlebik/the ICRPhase III trial results on a precision radiotherapy technique support a "new gold standard" for treating hea

Updated on: January 04,2024

Trial results support 'new gold standard' for head and neck cancer radiotherapy

byInstitute of Cancer ResearchRadiotherapy IMRT. Credit: Jan Chlebik/the ICRPhase III trial results on a precision radiotherapy technique support a "new gold standard" for treating hea

Updated on:January 04,2024

Boosting the cancer-destroying ability of killer T-cells

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainMore types of cancer could potentially be destroyed by patients' own immune cells, thanks to new research by Cardiff University.The

Updated on: April 18,2024

Boosting the cancer-destroying ability of killer T-cells

by Julia Short,Cardiff UniversityCredit: CC0 Public DomainMore types of cancer could potentially be destroyed by patients' own immune cells, thanks to new research by Cardiff University.The

Updated on:April 18,2024

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on: August 26,2024

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on:August 26,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on: March 20,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on:March 20,2024

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on: June 01,2024

Researchers confirm links between aggressive prostate cancer and hereditary breast cancer

by The Spanish National Cancer Research CentreDavid Olmos and Elena Castro, from the CNIO Prostate Cancer Clinical Research Unit. Credit: CNIOAggressive prostate cancer, one of the leading causes

Updated on:June 01,2024

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on: January 10,2024

How do we overcome treatment resistance in a sarcoma cancer with already limited treatment options?

by Elena Daviter-Nowell,Institute of Cancer ResearchHistopathology image of leiomyosarcoma. Credit:Wikimedia Commons, CC-BY-SA 4.0Leiomyosarcoma is a type of soft tissue sarcoma that is ha

Updated on:January 10,2024

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Updated on: June 11,2024

Researchers unlock cancer cells' feeding mechanism, central to tumor growth

by University of CincinnatiAtsuo Sasaki, Ph.D., associate professor at the UC College of Medicine Credit: Colleen Kelley / UC Creative ServicesAn international team led by researchers from the Un

Updated on:June 11,2024